UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2853) 2853
Newsletter (14) 14
Book Chapter (9) 9
Newspaper Article (4) 4
Magazine Article (3) 3
Dissertation (2) 2
Publication (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2492) 2492
mitoxantrone - administration & dosage (1965) 1965
science & technology (1876) 1876
life sciences & biomedicine (1815) 1815
female (1699) 1699
middle aged (1502) 1502
male (1478) 1478
antineoplastic combined chemotherapy protocols - therapeutic use (1399) 1399
adult (1276) 1276
biological and medical sciences (1156) 1156
medical sciences (1148) 1148
aged (1106) 1106
oncology (1012) 1012
mitoxantrone (934) 934
chemotherapy (848) 848
pharmacology. drug treatments (806) 806
antineoplastic agents (753) 753
cytarabine - administration & dosage (640) 640
antineoplastic combined chemotherapy protocols - adverse effects (594) 594
treatment outcome (590) 590
mitoxantrone - adverse effects (569) 569
hematology (518) 518
remission induction (478) 478
mitoxantrone - therapeutic use (453) 453
etoposide - administration & dosage (426) 426
cyclophosphamide - administration & dosage (407) 407
antineoplastic combined chemotherapy protocols - administration & dosage (398) 398
adolescent (376) 376
breast neoplasms - drug therapy (367) 367
animals (357) 357
drug administration schedule (357) 357
antineoplastic agents - administration & dosage (328) 328
leukemia, myeloid, acute - drug therapy (303) 303
cancer (298) 298
combined modality therapy (294) 294
disease-free survival (280) 280
vincristine - administration & dosage (278) 278
survival analysis (276) 276
survival rate (267) 267
aged, 80 and over (265) 265
pharmacology & pharmacy (263) 263
prednisone - administration & dosage (258) 258
doxorubicin - administration & dosage (254) 254
prognosis (254) 254
antineoplastic agents - therapeutic use (250) 250
dose-response relationship, drug (227) 227
tumors (227) 227
follow-up studies (208) 208
recurrence (204) 204
abridged index medicus (203) 203
mitoxantrone hydrochloride (200) 200
lymphoma, non-hodgkin - drug therapy (199) 199
daunorubicin - administration & dosage (194) 194
multiple sclerosis (191) 191
hematologic and hematopoietic diseases (190) 190
acute disease (186) 186
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (180) 180
time factors (179) 179
methotrexate - administration & dosage (176) 176
mice (175) 175
mitoxantrone - pharmacology (175) 175
prostatic neoplasms - drug therapy (174) 174
breast neoplasms - pathology (171) 171
drug evaluation (167) 167
retrospective studies (165) 165
breast cancer (164) 164
fluorouracil - administration & dosage (161) 161
drug therapy (156) 156
prospective studies (156) 156
care and treatment (155) 155
mitoxantrone - pharmacokinetics (155) 155
neurosciences & neurology (155) 155
medicine & public health (144) 144
research (144) 144
vidarabine - analogs & derivatives (143) 143
leukemia, myeloid - drug therapy (142) 142
prednisolone - administration & dosage (141) 141
clinical neurology (138) 138
neoplasm staging (137) 137
vidarabine - administration & dosage (137) 137
salvage therapy (134) 134
multiple sclerosis - drug therapy (131) 131
prostate cancer (131) 131
antineoplastic agents - adverse effects (130) 130
drug resistance, neoplasm (130) 130
cisplatin - administration & dosage (129) 129
child (126) 126
cell line, tumor (124) 124
antineoplastic agents - pharmacology (122) 122
neoplasm metastasis (121) 121
cytarabine - adverse effects (118) 118
clinical trials as topic (109) 109
neurology (109) 109
rituximab (108) 108
hematopoietic stem cell transplantation (107) 107
health aspects (106) 106
acute myeloid leukemia (105) 105
disease progression (103) 103
leukemia (101) 101
drug resistance (100) 100
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2682) 2682
Japanese (105) 105
German (64) 64
Chinese (45) 45
French (29) 29
Spanish (18) 18
Russian (15) 15
Czech (6) 6
Hungarian (4) 4
Italian (4) 4
Polish (3) 3
Ukrainian (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
Journal Article
Annals of oncology, ISSN 0923-7534, 03/2011, Volume 22, Issue 3, pp. 664 - 670
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2009 - 2017
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Chemotherapy | Pharmacology. Drug treatments | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Recurrence | Cyclophosphamide - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Female | Leukocyte Count | Child | Idarubicin - therapeutic use | Mitoxantrone - therapeutic use | Dexamethasone - administration & dosage | Risk Assessment | Kaplan-Meier Estimate | Mercaptopurine - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | United Kingdom | Vidarabine - analogs & derivatives | Cytarabine - administration & dosage | Polyethylene Glycols - administration & dosage | Asparaginase - administration & dosage | Disease-Free Survival | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Vidarabine - administration & dosage | Complications and side effects | Dosage and administration | Acute lymphocytic leukemia | Drug therapy | Patient outcomes | Mitoxantrone hydrochloride | Studies | Design | Medical research | Databases | Cytogenetics | Cancer therapies | Cancer | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9747, pp. 1147 - 1154
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Prostatic Neoplasms - metabolism | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Prostatic Neoplasms - immunology | Antineoplastic Agents, Hormonal - therapeutic use | Treatment Failure | Neutropenia - chemically induced | Mitoxantrone - adverse effects | Prostatic Neoplasms - drug therapy | Taxoids - adverse effects | Prostatic Neoplasms - pathology | Prednisone - administration & dosage | Prednisone - adverse effects | Drug Administration Schedule | Administration, Oral | Kaplan-Meier Estimate | Treatment Outcome | Disease Progression | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Biomarkers, Tumor - blood | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Androgen Antagonists - therapeutic use | Aged | Infusions, Intravenous | Pain Measurement | Dosage and administration | Prednisone | Research | Drug therapy | Prostate cancer | Mitoxantrone hydrochloride | Studies | Chemotherapy | Medical imaging | Physicians | Family medical history | Radiation therapy | Clinical medicine | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 03/2011, Volume 117, Issue 5, pp. 1010 - 1018
chemo‐immunotherapy | midtreatment PET | primary mediastinal large B cell lymphoma | aggressive non‐Hodgkin lymphoma | 18F‐fluorodeoxyglucose positron‐emission tomography | Midtreatment PET | Primary mediastinal large B cell lymphoma | Chemo-immunotherapy | 18F-fluorodeoxyglucose positron-emission tomography | Aggressive non-Hodgkin lymphoma | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Leucovorin - administration & dosage | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Lymphoma, Non-Hodgkin - diagnostic imaging | Lymphoma, Non-Hodgkin - pathology | Young Adult | Time Factors | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Lymphoma, Non-Hodgkin - drug therapy | Prednisone - administration & dosage | Drug Administration Schedule | Neoplasm Invasiveness | Rituximab | Etoposide - administration & dosage | Bleomycin - administration & dosage | Positron-Emission Tomography - methods | Algorithms | Adolescent | Survival Analysis | Monitoring, Physiologic - methods | Fluorodeoxyglucose F18 | Methotrexate - administration & dosage | Aged | Lymphoma, Non-Hodgkin - mortality | Neoplasm Staging | Care and treatment | Usage | Prognosis | PET imaging | Patient outcomes | Non-Hodgkin's lymphomas | Research | Index Medicus | Abridged Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 05/2020, Volume 26, Issue 10, pp. 2297 - 2307
Journal Article